Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha-gal epitope (Galactose-alpha-1,3-galactose) is a carbohydrate structure found on glycoproteins and glycolipids of non-primate mammals and some other organisms. Humans naturally produce anti-alpha-gal antibodies. In certain individuals, tick bites or specific environmental factors can lead to the production of anti-alpha-gal IgE, underlying alpha-gal syndrome, an allergy where exposure to mammalian products containing alpha-gal triggers delayed allergic reactions. Anti-alpha-gal antibodies are also implicated in hyperacute rejection during xenotransplantation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Galactose-alpha-1,3-galactose (Alpha-gal).